ARTICLE | Emerging Company Profile
Versant-founded immunology play launches with $168M to create biologics targeted to specific cell types
By Danielle Golovin, Senior Biopharma Analyst
June 13, 2024 11:00 PM UTC
Santa Ana is leveraging learnings from precision oncology and combining them with advances in protein engineering capabilities to create biologics for precision immunology.
Santa Ana Bio Inc. uses genomic, transcriptomic and proteomic approaches to characterize patient subpopulations and identify targets expressed only on disease-causing cell types, leaving healthy cells unaffected…
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/652667/santa-ana-leveraging-human-multi-omic-data-for-precision-immunology